Ingredients

News in Brief

Delmar to pump $46m into Canadian API plant

07-Feb-2018 By Staff Reporter

Italian API maker Delmar Chemicals will up production capacity at a plant in Quebec, Canada.

AstraZeneca aims for ZS Pharma kidney drug approvals in H1 2018

06-Feb-2018 By Dan Stanton

AstraZeneca says its hyperkalaemia candidate ZS-9 is back on track for approval after manufacturing issues at its Texas facility resulted in regulatory delays.

Merck consumer health sale ‘at risk’ after Nestlé pull out

05-Feb-2018 By Nathan Gray

The sale of Merck KGaA’s consumer health unit is at risk after leading bidder Nestlé left the race for the business, sources have suggested.

Danish regulators slam Indian API maker for GMP failings

05-Feb-2018 By Staff Reporter

Kadam Exports Private has received a statement of non-compliance with GMP after the Danish Medicines Agency found manufacturing deficiencies at its facility in Gujarat.

Japanese API maker accused of falsifying data by US FDA

31-Jan-2018 By Dan Stanton

The US FDA has slammed Daito Kasei Kogyo Co in a warning letter for data integrity issues.

Quality surveyor? Rephine launches QA documentation database for APIs

24-Jan-2018 By Dan Stanton

Rephine says its online Quality Assurance database transforms the lengthy active pharmaceutical ingredient (API) pre-selection process to just a couple of clicks.

Researchers target African arrow poison for male birth control

23-Jan-2018 By Flora Southey

Scientists say a modified plant extract traditionally used as an arrow poison in eastern Africa could inhibit sperm cells’ ability to swim, and lead to the development of a male contraceptive pill.

Environmental tax will impact firms that use China-made drug intermediates say experts

22-Jan-2018 By Gareth Macdonald

China’s environmental tax will mean higher costs for drug and API firms that rely on intermediates made in the country say industry experts.

API firms that pollute will pay under new Chinese tax law

18-Jan-2018 By Gareth Macdonald

Chinese API firms that pollute will have to pay a tax to local Government rather than a fee per discharge under newly introduced legislation.

news in brief

Ipca buys API firm Pisgah Labs

18-Jan-2018 By Gareth Macdonald

Ipca Pharmaceutical Inc. has acquired North Carolina drug ingredient firm Pisgah Labs for $9.65m.

Telix sets up subsidiary to make and trial radio-labelled meds in Japan

17-Jan-2018 By Gareth Macdonald

Radiopharmaceuticals firm Telix Pharmaceuticals Limited has established a subsidiary in Japan to support clinical development and manufacturing activities.

Chinese penicillin API maker slammed for GMP failures

16-Jan-2018 By Dan Stanton

Belgian regulators have issued Chinese antibiotic maker Inner Mongolia Changsheng Pharmaceutical Co. with a certificate of non-compliance.

Scientists look to regenerative 'chemo-catalyst' for more selective cancer drugs

16-Jan-2018 By Flora Southey

A natural substance found in stinging nettles and ants repeatedly attacks cancer within cells, say scientists developing low-dose alternatives to current chemotherapy drugs.

Teva timeline: CEO says 20-25 manufacturing plants to close in next two years

11-Jan-2018 By Gareth Macdonald

Teva Pharmaceutical Industries has confirmed it will close 20 to 25 API and drug manufacturing plants over the next two years.

News in brief

API distributor American International Chemical bought by private equity firm

10-Jan-2018 By Gareth Macdonald

Investment firm LeBaronBrown Llc has acquired American International Chemical Inc (AIC), a distributor of ingredients for the pharmaceutical sector and other industries.